يعرض 1 - 20 نتائج من 44 نتيجة بحث عن '"Keeping S."', وقت الاستعلام: 0.47s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal

    المساهمون: Hess G., Dreyling M., Oberic L., Gine E., Zinzani P.L., Linton K., Vilmar A., Jerkeman M., Chen J.M.H., Ohler A., Stilgenbauer S., Thieblemont C., Lambert J., Zilioli V.R., Sancho J.-M., Ubieto A.J., Fischer L., Eyre T.A., Keeping S., Park J.E., Wu J.J., Siddiqi R., Reitan J., Wade S., Salles G.

    وصف الملف: ELETTRONICO

    Relation: info:eu-repo/semantics/altIdentifier/pmid/36257914; info:eu-repo/semantics/altIdentifier/wos/WOS:000869616600001; volume:202; issue:4; firstpage:749; lastpage:759; numberofpages:11; journal:BRITISH JOURNAL OF HAEMATOLOGY; https://hdl.handle.net/11585/904781; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85140099104

  3. 3
  4. 4
    Academic Journal

    المساهمون: ABB Switzerland Ltd, Group Technology Management

    المصدر: IEEE Internet of Things Journal ; volume 9, issue 16, page 14325-14335 ; ISSN 2327-4662 2372-2541

  5. 5
  6. 6
    Academic Journal
  7. 7
    Academic Journal
  8. 8
    Academic Journal
  9. 9
    Academic Journal
  10. 10
    Academic Journal
  11. 11
    Academic Journal
  12. 12
    Academic Journal

    المساهمون: The Manchester Cancer Research Center, Manchester, UK

    Relation: https://dx.doi.org/10.1080/10428194.2023.2268228; Hess G, Dreyling M, Oberic L, Gine E, Zinzani PL, Linton K, et al. Indirect treatment comparison of brexucabtagene autoleucel (ZUMA-2) versus standard of care (SCHOLAR-2) in relapsed/refractory mantle cell lymphoma. LEUKEMIA & LYMPHOMA. 2023 2023 OCT 14. PubMed PMID: WOS:001086585900001. English.; http://hdl.handle.net/10541/626728; Leukemia & Lymphoma

  13. 13
    Academic Journal
  14. 14
    Academic Journal
  15. 15
  16. 16
  17. 17
    Conference

    المساهمون: Department of Hematology, Oncology and Pneumology, Comprehensive Cancer Center, University Medical School of the Johannes Gutenberg-University, Mainz

    Relation: https://dx.doi.org/10.1182/blood-2022-162638; Hess G, Dreyling M, Oberic L, Gine E, Zinzani PL, Linton KM, et al. A Comparison of Overall Survival with Brexucabtagene Autoleucel (Brexu-cel) CAR T-Cell Therapy (ZUMA-2) and Standard of Care (SCHOLAR-2) in Patients with Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL) Previously Treated with a Covalent Bruton Tyrosine Kinase Inhibitor (BTKi). Blood. 2022 Nov;140:10296-9. PubMed PMID: WOS:000893230303139.; http://hdl.handle.net/10541/626208; Blood

  18. 18
  19. 19
    Academic Journal
  20. 20
    Academic Journal